Biopharmaceutical Company's Stock Plunges 75% After FDA Rejects New Drug - Inkl

Retrieved on: 2024-11-30 00:18:13

Tags for this article:

Click the tags to see associated articles and topics

Biopharmaceutical Company's Stock Plunges 75% After FDA Rejects New Drug - Inkl. View article details on hiswai:

Excerpt

Applied Therapeutics' stock plummeted 75 percent after the Food and Drug Administration (FDA) rejected approving govorestat as a treatment for…

Article found on: www.inkl.com